Sonia Trope
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Artificial intelligence in healthcare faces regulatory challenges: balancing innovation with human oversight.
Journal: EULAR rheumatology open
Published: June 29, 2026
"It was red, it was inflamed": A qualitative study of patient perspectives on musculoskeletal ultrasound in rheumatoid arthritis care.
Journal: Patient education and counseling
Published: May 13, 2025
The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs.
Journal: Journal of multidisciplinary healthcare
Published: March 14, 2025
Survey of adolescents' needs and parents' views on sexual health in juvenile idiopathic arthritis.
Journal: Pediatric rheumatology online journal
Published: June 06, 2023
Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis.
Journal: Rheumatology international
Published: November 09, 2021
Development and real-life use assessment of a self-management smartphone application for patients with inflammatory arthritis. A user-centred step-by-step approach.
Journal: PloS one
Published: September 11, 2021
Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting.
Journal: Patient preference and adherence
Published: January 14, 2021
Patients and spouses coping with inflammatory arthritis: Impact of communication and spousal perceived social support and burden.
Journal: Joint bone spine
Published: July 04, 2020
Preconceived notions about biosimilars-a French experience.
Journal: Clinical rheumatology
Published: May 07, 2020
Patients' information and perspectives on biosimilars in rheumatology: A French nation-wide survey.
Journal: Joint bone spine
Published: September 22, 2018
Biosimilars: complements and comments on the recent statement of the SFR and CRI. Comment on: "Biosimilars: An opportunity. Position statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI)." Schaeverbeke et al. Joint Bone Spine 2018;95:399-402.
Journal: Joint bone spine
Published: August 01, 2018
Last Updated: 09/26/2026